Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Provenge

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Cancer immunotherapy has recently emerged as an important treatment modality. FDA approval of provenge, ipilimumab and… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Therapies for prostate cancer depend on age, rate of the cancer’s growth, the specific benefits and drawbacks of treatment, and… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
  • Vicki Brower
  • Journal of the National Cancer Institute
  • 2010
  • Corpus ID: 33468632
Adecade in development, Dendreon’s prostate cancer vaccine, sipuleucelT (Provenge), has become the first therapeutic cancer… Expand
Is this relevant?